T. Rowe Price Associates’s IMS HEALTH HLDGS INC COM STK (DE) IMS Stock Holding History

T. Rowe Price Associates’s Portfolio IMS Stock Details IMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,870,626	Closed	-$278M	–	2618
2016 Q3	$278M	Buy	8,870,626 +183,311	+2%	+$5.36M	0.06%	330
2016 Q2	$220M	Buy	8,687,315 +135,195	+2%	+$3.47M	0.05%	387
2016 Q1	$227M	Buy	8,552,120 +117,167	+1%	+$2.91M	0.05%	363
2015 Q4	$215M	Buy	8,434,953 +595,413	+8%	+$16.6M	0.05%	382
2015 Q3	$228M	Buy	7,839,540 +105,100	+1%	+$3.23M	0.05%	381
2015 Q2	$237M	Buy	7,734,440 +4,875,400	+171%	+$141M	0.05%	402
2015 Q1	$77.4M	Buy	2,859,040 +525,950	+23%	+$13.6M	0.02%	688
2014 Q4	$59.8M	Buy	2,333,090 +69,100	+3%	+$1.74M	0.01%	783
2014 Q3	$59.3M	Buy	2,263,990 +14,890	+0.7%	+$401K	0.01%	769
2014 Q2	$57.8M	Buy	+2,249,100	New	+$54.1M	0.01%	819

T. Rowe Price Associates's IMS Position: Q4 2016 in Review

T. Rowe Price Associates sold out of IMS HEALTH HLDGS INC COM STK (DE) (IMS) in Q4 2016, closing a stake of 8,870,626 shares — an estimated $278M sold.

T. Rowe Price Associates first reported a position in IMS in Q2 2014 and held it in 10 quarters. The position peaked at $278M in Q3 2016. 0 funds tracked by Wall St. Rank hold IMS as of Q4 2016.

T. Rowe Price Associates reported no remaining IMS HEALTH HLDGS INC COM STK (DE) position as of Q4 2016 after selling out during the quarter.
T. Rowe Price Associates sold 8,870,626 IMS HEALTH HLDGS INC COM STK (DE) shares in Q4 2016, an estimated $278M.
T. Rowe Price Associates first reported a position in IMS HEALTH HLDGS INC COM STK (DE) in Q2 2014 and held it in 10 quarters.
T. Rowe Price Associates's IMS HEALTH HLDGS INC COM STK (DE) position peaked at $278M in Q3 2016.
0 funds tracked by Wall St. Rank held IMS HEALTH HLDGS INC COM STK (DE) as of Q4 2016.

Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.